Ardelyx's Series B Round

Ardelyx raised a round of funding on August 16, 2011.

Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, non-systemic, small molecule therapeutics that work exclusively in the …

Articles about Ardelyx's Series B Round: